Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. LMND
LMND logo

LMND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lemonade Inc (LMND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
53.240
1 Day change
-1.55%
52 Week Range
99.900
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Lemonade Inc (LMND) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the company shows strong revenue growth and customer acquisition, the stock's recent performance, negative sentiment, and lack of clear technical or proprietary trading signals suggest that it is better to hold off on buying for now.

Technical Analysis

The MACD is slightly positive, indicating a mild bullish trend, but RSI is neutral at 45.807, showing no clear momentum. Moving averages are converging, suggesting indecision in the market. The pre-market price is slightly down (-0.31%), and the stock is trading near its pivot level of 54.118, with resistance at 58.854 and support at 49.381.

Options Data

Bullish
Open Interest Put-Call Ratio
Neutral
Option Volume Put-Call Ratio

The open interest put-call ratio of 0.55 indicates more call interest, suggesting mild bullish sentiment, but the option volume put-call ratio of 0.95 shows balanced trading sentiment. Implied volatility (76.84) is moderate, with an IV rank of 22.67, indicating the stock is not currently in a high-volatility regime.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
1

Positive Catalysts

  • Revenue growth of 53% YoY in Q4

  • Improved loss ratio of 64%.

  • Increasing customer count by 23% YoY.

  • Analysts highlight Lemonade's AI-driven cost advantages and automation potential.

Neutral/Negative Catalysts

  • Stock fell 36% in February due to investor impatience and market volatility.

  • Net income and EPS have declined significantly YoY.

  • Analysts express concerns about achieving sustained growth amid competition.

  • No recent congress trading or significant insider/hedge fund activity.

Financial Performance

In Q4 2025, revenue increased to $228.1M (+53.29% YoY), but net income dropped to -$21.7M (-27.67% YoY), and EPS fell to -0.29 (-30.95% YoY). Gross margin remains at 0%. While revenue growth is strong, profitability remains a concern.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed: Keefe Bruyette has an Underperform rating with a $44 price target, citing challenges in achieving growth. Piper Sandler is Neutral with a $65 target, while Truist and Morgan Stanley are more optimistic with Buy and Equal Weight ratings, respectively, and price targets of $98 and $85. However, concerns about competition and profitability persist.

Wall Street analysts forecast LMND stock price to rise
6 Analyst Rating
Wall Street analysts forecast LMND stock price to rise
2 Buy
3 Hold
1 Sell
Hold
Current: 54.080
sliders
Low
40
Averages
77.6
High
98
Current: 54.080
sliders
Low
40
Averages
77.6
High
98
Keefe Bruyette
Underperform
maintain
$40 -> $44
AI Analysis
2026-02-24
Reason
Keefe Bruyette
Price Target
$40 -> $44
AI Analysis
2026-02-24
maintain
Underperform
Reason
Keefe Bruyette raised the firm's price target on Lemonade to $44 from $40 and keeps an Underperform rating on the shares. 30%+ growth, sustained low loss ratios, and efficient customer acquisition spend could be "challenging" to achieve in synchrony with intensifying competition, the analyst tells investors in a research note.
Piper Sandler
Neutral
downgrade
$85 -> $65
2026-02-19
Reason
Piper Sandler
Price Target
$85 -> $65
2026-02-19
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Lemonade to $65 from $85 and keeps a Neutral rating on the shares following Q4 results. The firm told investors that the stock traded down due to the company not moving forward its adjusted EBITDA profitability target despite better underwriting and commentary around initiatives to better drive bunding, price and automation that Piper believes investors think will prove costly. However, the firm believes these concerns are "overly simplistic" given Lemonade is arguably the direct-to-consumer personal lines insurance grocery store more and more automating the ecosystem.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LMND
Unlock Now

People Also Watch